A stock market site by Business Insider with real-time data, custom charts and breaking news. Get the latest on stocks, commodities, currencies, funds, rates, ETFs, and more.

  • 1,011articles · 30d
  • 6+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 88%with images
  • 307avg words
articles per day
Categories
  • Economy, Business & Finance 782
  • Finance & Business 606
  • Finance 217
  • News 162
  • Business & Industrial 130
  • Health & Wellness 70
  • Medical 57
  • Transportation 49

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

markets.businessinsider.com
markets.businessinsider.com > news > stocks > baycare-generates-13-billion-in-economic-impact-annually-for-florida-1036532627

BayCare Generates $13 Billion in Economic Impact Annually for Florida

4+ day, 11+ hour ago   (477+ words) BayCare 16 hospitals provide the largest portion of economic impact at $8.7 billion. BayCare Medical Group, the region’s largest multispecialty physician group, grew by 154% to $1.9 billion. BayCare Generates $13 Billion in Economic Impact Annually for Florida CLEARWATER, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- BayCare’s commitment…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > rema-hort-mann-fund-celebrates-30-years-of-art-and-care-with-milestone-gala-and-launch-of-new-chapter-of-expanded-grantmaking-with-artists-living-with-cancer-grant-1036536984

Rema Hort Mann Fund Celebrates 30 Years of Art and Care with Milestone Gala and Launch of New Chapter of Expanded Grantmaking with Artists Living with Cancer Grant

3+ day, 8+ hour ago   (296+ words) New York City, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ABOUT RHMF’s 30th ANNIVERSARY GALA HONOREES Susan Hort, a passionate advocate for early-career artists, is also a revered philanthropist and seasoned collector of contemporary art. Listed numerous times on the ARTnews Top 200 Collector List, alongside…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > oncolytics-biotech-announces-positive-preclinical-results-combining-pelareorep-with-a-pan-ras-inhibitor-in-colorectal-cancer-1036535740

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

3+ day, 13+ hour ago   (398+ words) Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibitionFindings support further evaluation of pelareor... Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer Preclinical results demonstrate pelareorep activity is maintained…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > hexiris-ophthalmics-to-present-first-in-human-obi-glaucoma-data-at-five-fall-meetings-beginning-with-the-ophthalmology-futures-forum-in-london-1036534884

Hexiris Ophthalmics to Present First-in-Human OBi Glaucoma Data at Five Fall Meetings, Beginning with the Ophthalmology Futures Forum in London

3+ day, 19+ hour ago   (430+ words) Hexiris was founded by surgeons Dr. Houfar Sekhavat and Dr. Nir Shoham-Hazon after humanitarian missions in Gabon, Mozambique and Mexico, where they saw the same reality in every clinic: effective treatments for glaucoma exist, but far too many patients cannot…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > allogenetics-raises-3-8-million-pre-series-a-to-advance-novel-ex-vivo-gene-therapy-approach-to-improve-organ-transplantation-outcomes-1036531415

Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes

4+ day, 16+ hour ago   (533+ words) Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantationRound was led by NBank... Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes - Financing will support…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > john-briggs-launches-productivity-work-life-balance-course-on-the-3-3-rule-1036538083

John Briggs Launches Productivity & Work-Life Balance Course On The 3.3 Rule

2+ day, 9+ hour ago   (169+ words) John Briggs, CPA and CEO of Incite Tax, has launched his on-demand Take Breaks, Work Better course, introducing business owners and their teams to the 3.3 Rule for improving productivity while supporting better work-life balance. "Most business owners are measuring the…...

Google News
markets.businessinsider.com > news > stocks > rad-source-technologies-introduces-sterile-insect-farms-1036536501

Rad Source Technologies Introduces Sterile Insect Farms™ | Markets Insider

2+ day, 23+ hour ago   (382+ words) Rad Source Technologies Introduces Sterile Insect Farms™ markets.businessinsider.com Rad Source Technologies Introduces Sterile Insect Farms™ BUFORD, Ga., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, a leading innovator in X-ray solutions for life sciences, is proud to announce Sterile Insect…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > the-bodymind-workout-announces-dr-desi-bartlett-s-new-perimenopause-and-midlife-programming-partnership-with-glo-1036537256

The BodyMind Workout Announces Dr. Desi Bartlett’s New Perimenopause and Midlife Programming Partnership With Glo

2+ day, 20+ hour ago   (298+ words) Honolulu, HI, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The BodyMind Workout®, founder Dr. Desi Bartlett, Ed.D., today announced a new partnership with Glo, the premier online destination for yoga, meditation, and fitness, to launch new programming for women navigating perimenopause and midlife....

markets.businessinsider.com
markets.businessinsider.com > news > stocks > discovering-the-formula-for-health-in-yogurt-9th-bright-dairy-yogurt-cultural-festival-concludes-in-bulgaria-1036530775

Discovering the Formula for Health in Yogurt: 9th Bright Dairy Yogurt Cultural Festival Concludes in Bulgaria

4+ day, 20+ hour ago   (247+ words) SHANGHAI, Sept. 09, 2026 (GLOBE NEWSWIRE) -- The 9th Bright Dairy Yogurt Cultural Festival has successfully concluded in Momchilovtsi, a longevity village in Bulgaria's Central Rhodope Mountains. Hosted by Bright Dairy, the 2026 event was themed "Discovering the Formula for Health in Yogurt." It focused…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > adneuris-therapeutics-presents-novel-data-on-lead-candidate-cebranopadol-for-the-treatment-of-moderate-to-severe-acute-pain-at-painweek-2026-1036536586

Adneuris Therapeutics Presents Novel Data on Lead Candidate, Cebranopadol for the Treatment of Moderate-to-Severe Acute Pain at PAINWeek 2026

2+ day, 21+ hour ago   (261+ words) Adneuris unveiled new abuse potential data demonstrating that cebranopadol's abuse potential may be lower than that of Schedule II and Schedule IV pain drugs, further differentiating its dual NOP/MOP mechanism from drugs like oxycodone. The Phase 3 ALLEVIATE studies met…...